Description

Artificial intelligence for drug discovery.Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.

 


ACTIVE FOUNDERS

Founder 1

Abraham Heifets,

Abraham Heifets is cofounder and CEO of Atomwise. He was a Massey Fellow at the University of Toronto and the Ontario Brain Institute, where his doctoral work used machine learning to plan organic syntheses, a long-standing challenge in chemistry. Previously, Abraham researched compilers for high-performance data processing at IBM's T.J. Watson Research Center and helped build the AI system of the world-champion robotic soccer team at Cornell University. He was Time's Person of the Year in 2006.

Twitter: https://twitter.com/AbeHeifets | Linkedin: http://ca.linkedin.com/in/abrahamheifets


Founder 2

Izhar Wallach,

Twitter: | Linkedin: https://www.linkedin.com/in/izhar-wallach-a0403811/


Founder 3

,

Twitter: | Linkedin:


Founder 4

,

Twitter: | Linkedin:


Founder 5

,

Twitter: | Linkedin:


Founder 6

,

Twitter: | Linkedin:

Based in

San Francisco

Nation
Team Size

50

Not Available
Today's work schedule is not available
  • Monday

    By appointment only

  • Tuesday

    N/A

  • Wednesday

    N/A

  • Thursday

    N/A

  • Friday

    N/A

  • Saturday

    N/A

  • Sunday

    N/A

  • 30 September 2022 15:43 local time

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected